C200-2373 Screening compound: 3-{4-benzyl-5-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-1-yl}-N-(1-benzylpiperidin-4-yl)propanamide

C200-2373 Screening compound: 3-{4-benzyl-5-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-1-yl}-N-(1-benzylpiperidin-4-yl)propanamide
C200-2373 Screening compound: 3-{4-benzyl-5-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-1-yl}-N-(1-benzylpiperidin-4-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C200-2373
3-{4-benzyl-5-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-1-yl}-N-(1-benzylpiperidin-4-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C200-2373

Molecular Formula

C31H32N6O2 (C31 H32 N6 O2)

Compound Name

3-{4-benzyl-5-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-1-yl}-N-(1-benzylpiperidin-4-yl)propanamide

IUPAC name

3-{4-benzyl-5-oxo-4H5H-[124]triazolo[43-a]quinazolin-1-yl}-N-(1-benzylpiperidin-4-yl)propanamide

SMILES

O=C(CCc(n1-c2c3cccc2)nnc1N(Cc1ccccc1)C3=O)NC1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C31H32N6O2/c38-29(32-25-17-19-35(20-18-25)21-23-9-3-1-4-10-23)16-15-28-33-34-31-36(22-24-11-5-2-6-12-24)30(39)26-13-7-8-14-27(26)37(28)31/h1-14,25H,15-22H2,(H,32,38)

InChI Key

YATGIYPWGUZWLK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14726476

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

520.63

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.148

Distribution Coefficient, logD

1.590

Water Solubility, LogSw

-3.62

Polar Surface Area

67.444

Acid Dissociation Constant (pKa)

16.14

Base Dissociation Constant (pKb)

8.95

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.00

C200-2373 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C200-2373 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C200-2373?
Check Price and Availability of C200-2373, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C200-2373 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C200-2373
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C200-2373
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C200-2373 available by request